Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BAMLANIVIMAB Cause Wrong technique in product usage process? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Wrong technique in product usage process have been filed in association with BAMLANIVIMAB. This represents 0.2% of all adverse event reports for BAMLANIVIMAB.

9
Reports of Wrong technique in product usage process with BAMLANIVIMAB
0.2%
of all BAMLANIVIMAB reports
0
Deaths
1
Hospitalizations

How Dangerous Is Wrong technique in product usage process From BAMLANIVIMAB?

Of the 9 reports, 1 (11.1%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BAMLANIVIMAB. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does BAMLANIVIMAB Cause?

Dyspnoea (833) Infusion related reaction (663) Pyrexia (641) Chills (453) Oxygen saturation decreased (448) Nausea (422) Covid-19 (346) Cough (342) Covid-19 pneumonia (313) Hypoxia (310)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which BAMLANIVIMAB Alternatives Have Lower Wrong technique in product usage process Risk?

BAMLANIVIMAB vs BAMLANIVIMAB\ETESEVIMAB BAMLANIVIMAB vs BARACLUDE BAMLANIVIMAB vs BARICITINIB BAMLANIVIMAB vs BARIUM BAMLANIVIMAB vs BARNIDIPINE

Related Pages

BAMLANIVIMAB Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process BAMLANIVIMAB Demographics